These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6277111)
21. [An acellular pertussis vaccine based on the natural complex of antigens isolated from the supernatant of a synthetic culture medium]. Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MH; Britsina MV; Shmeleva EI; Mertsalova NU; Ermolova EI; Sukhinova EE; Bulk VF; Sirotinskiĭ AV; Poluiianova AG; Sviridov VV; Vartanian IuP Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):67-70. PubMed ID: 9304334 [TBL] [Abstract][Full Text] [Related]
22. Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: current diagnostic procedures in whooping cough. Holwerda J Health Lab Sci; 1971 Oct; 8(4):206-9. PubMed ID: 4329893 [No Abstract] [Full Text] [Related]
23. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model. Komatsu E; Yamaguchi F; Eguchi M; Watanabe M Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876 [TBL] [Abstract][Full Text] [Related]
24. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908 [TBL] [Abstract][Full Text] [Related]
25. [The effect of methylated cyclodextrin on pertussis toxin accumulation in a Bordetella pertussis culture in a bioreactor]. Siundiukova RA; Basnak'ian IA; Stukalova NV; Aleksakhina NN Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):14-7. PubMed ID: 10876840 [TBL] [Abstract][Full Text] [Related]
30. [The expression of Bordetella pertussis protective antigens during bacterial multiplication on a medium with a fixed chemical composition]. Shmeleva EI; Mertsalova NU; Sukhinova EV; Kirillova GA; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Britsina MV; Ermolova EV; Zakharova NS Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):47-50. PubMed ID: 9245141 [TBL] [Abstract][Full Text] [Related]
31. Comparison of biological activities of Bordetella pertussis mutants lacking the ability to produce filamentous hemagglutinin with similar activities of other smooth strains. Watanabe M; Munoz JJ Microbiol Immunol; 1982; 26(10):965-9. PubMed ID: 6298581 [No Abstract] [Full Text] [Related]
32. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566 [TBL] [Abstract][Full Text] [Related]
33. [The cultivation of Bordetella pertussis under different conditions and a study of the cultures obtained]. Nikolaeva VB; Roshchupkina MN; Gruber IM; Sviridov VV Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):13-4. PubMed ID: 7661907 [No Abstract] [Full Text] [Related]
34. [Physicochemical and biological characteristics of preparations of an antigenic complex isolated from the cultivation medium of Bordetella pertussis]. Semina IE; Bazhanova IG; Tsvetkova NV; Remova TN; Ozeretskovskaia MN Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):76-9. PubMed ID: 2904201 [TBL] [Abstract][Full Text] [Related]
35. Bordetella pertussis: why is it still circulating? Guiso N J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807 [TBL] [Abstract][Full Text] [Related]
36. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage. Gilberg S; Njamkepo E; Du Châtelet IP; Partouche H; Gueirard P; Ghasarossian C; Schlumberger M; Guiso N J Infect Dis; 2002 Aug; 186(3):415-8. PubMed ID: 12134239 [TBL] [Abstract][Full Text] [Related]
37. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642 [TBL] [Abstract][Full Text] [Related]
38. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis. Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216 [TBL] [Abstract][Full Text] [Related]
39. [Non-selection mechanism of antibody-induced stable antigenic variability of microorganisms. I. Patterns in the antigenic variability of Bordetella pertussis]. Kuzmetsov EA; Oleĭnik II Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):24-9. PubMed ID: 6277110 [No Abstract] [Full Text] [Related]
40. Study of a blood-free medium for transport and growth of Bordetella pertussis. Jones GL; Kendrick PL Health Lab Sci; 1969 Jan; 6(1):40-5. PubMed ID: 4305543 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]